Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca’s John Rex joins UK biotech F2G

Takes up the role of chief medical officer at the UK company

F2G John RexJohn Rex has moved from AstraZeneca to F2G to become the Manchester, UK-based drug discovery firm's chief medical officer.

He was previously a senior vice president at AZ, where he served as head of infection within its global medicines development unit, and he has been a non-executive director at F2G since 2012.

Ian Nicholson, chief executive officer at F2G, said: “John's guidance and insight have been instrumental in shaping F2G's development and regulatory strategy. We are delighted that he is now able to increase his commitment to the company as we progress our new class of antifungal agents into our next clinical trials.”  

In his new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials.

John Rex said: “I am delighted to have the opportunity to work more closely with F2G as we take the first orotomide antifungal forward through phase II and phase III. Just as with antibacterial resistance, antifungal resistance is a growing threat and F2G's discovery of an entirely novel class of IV/PO antifungal agent is a key part of the global response to this challenge.”

Prior to joining AstraZeneca in 2003, Rex was professor of medicine at the University of Texas Medical School and has previously served as the industry representative on the US FDA Anti-Infective Drug Advisory Committee.

5th December 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics